Benaroya Research Institute/Virginia Mason Medical Center — Seattle, Washington

Benaroya Research Institute/Virginia Mason Medical Center is a clinical research site located in Seattle, Washington, United States 98101.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Benaroya Research Institute/Virginia Mason Medical Center has participated in 3 clinical trials.

Therapeutic areas: Hodgkin Disease, Peripheral T Cell Lymphoma, Lymphoma, B-cell.

Sponsors: Seagen Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Seattle

Browse all research sites in Washington · View every site in Seattle

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Benaroya Research Institute/Virginia Mason Medical Center?

Benaroya Research Institute/Virginia Mason Medical Center has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Benaroya Research Institute/Virginia Mason Medical Center conducted?

Benaroya Research Institute/Virginia Mason Medical Center has 3 clinical trials on record. Their work covers Hodgkin Disease, Peripheral T Cell Lymphoma, Lymphoma, B-cell.

Is Benaroya Research Institute/Virginia Mason Medical Center accredited by Crixeo Clinical Trials?

Benaroya Research Institute/Virginia Mason Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Benaroya Research Institute/Virginia Mason Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.